7.33
price down icon5.78%   -0.45
after-market After Hours: 7.39 0.06 +0.82%
loading

Enanta Pharmaceuticals Inc Stock (ENTA) Latest News

pulisher
Mar 01, 2025

Investor Network: Enanta Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 01, 2025
pulisher
Feb 28, 2025

Enanta Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat

Feb 28, 2025
pulisher
Feb 24, 2025

(ENTA) Trading Advice - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 20, 2025

Market Watch Highlights: Enanta Pharmaceuticals Inc (ENTA) Ends on an Upturn Note at 8.30 - The Dwinnex

Feb 20, 2025
pulisher
Feb 19, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.com - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded to “Hold” at StockNews.com - Defense World

Feb 19, 2025
pulisher
Feb 17, 2025

HC Wainwright Has Pessimistic Outlook of ENTA Q2 Earnings - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Enanta Pharmaceuticals' SWOT analysis: RSV and immunology drive stock outlook - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Analysts Set Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Price Target at $17.25 - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) CEO Purchases $256,050.00 in Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Enanta Pharmaceuticals CEO Luly Jay R. buys $256,050 in common stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Cut to "Sell" at StockNews.com - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

JMP Securities maintains Enanta stock with $21 target - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns - Yahoo Finance

Feb 15, 2025
pulisher
Feb 15, 2025

President of Enanta Pharmaceuticals Picks Up 5.9% More Stock - Yahoo Finance

Feb 15, 2025
pulisher
Feb 15, 2025

Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Receives "Market Outperform" Rating from JMP Securities - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Shares Bounce 55% But Its Business Still Trails The Industry - Simply Wall St

Feb 14, 2025
pulisher
Feb 14, 2025

Enanta Pharmaceuticals’ (ENTA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Feb 14, 2025
pulisher
Feb 14, 2025

HC Wainwright maintains $18 target on Enanta shares, affirms Buy - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Releases Quarterly Earnings Results - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Enanta Pharmaceuticals Advances in Virology and Immunology - TipRanks

Feb 12, 2025
pulisher
Feb 12, 2025

Enanta Pharmaceuticals CEO Luly Jay R. buys $256,050 in common stock By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

ENANTA Pharmaceuticals CEO Acquires 45,000 Shares - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Enanta Pharmaceuticals Inc. (ENTA) reports earnings - Quartz

Feb 12, 2025
pulisher
Feb 12, 2025

ENANTA PHARMACEUTICALS INC SEC 10-Q Report - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by StockNews.com to “Sell” - Defense World

Feb 12, 2025
pulisher
Feb 11, 2025

JMP Securities maintains Enanta stock with $21 target By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 11, 2025

JMP Securities Reaffirms “Market Outperform” Rating for Enanta Pharmaceuticals (NASDAQ:ENTA) - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

HC Wainwright Reiterates Buy Rating for Enanta Pharmaceuticals (NASDAQ:ENTA) - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

The Analyst Verdict: Enanta Pharma In The Eyes Of 4 Experts - Benzinga

Feb 11, 2025
pulisher
Feb 11, 2025

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot - Huron Daily Tribune

Feb 11, 2025
pulisher
Feb 11, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024 - BioSpace

Feb 11, 2025
pulisher
Feb 10, 2025

Enanta Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2024 - Marketscreener.com

Feb 10, 2025
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Cap:     |  Volume (24h):